Target Name: USP53
NCBI ID: G54532
Review Report on USP53 Target / Biomarker Content of Review Report on USP53 Target / Biomarker
USP53
Other Name(s): Ubiquitin specific peptidase 53, transcript variant 2 | Inactive ubiquitin carboxyl-terminal hydrolase 53 | inactive ubiquitin-specific peptidase 53 | Inactive ubiquitin carboxyl-terminal hydrolase 53 (isoform 1) | KIAA1350 | ubiquitin specific proteinase 53 | Inactive ubiquitin-specific peptidase 53 | Ubiquitin specific proteinase 53 | UBP53_HUMAN | USP53 variant 2 | DKFZp781E1417 | ubiquitin specific protease 53 | PFIC7 | ubiquitin specific peptidase 53 | Ubiquitin specific protease 53

USP53: A Drug Target / Disease Biomarker

USP53 is a protein that is expressed in various tissues throughout the body. It is a key regulator of the DNA damage response, which is a critical process that helps the body repair damage to its DNA. USP53 has been identified as a potential drug target and is currently being targeted by researchers to develop new treatments for a variety of diseases.

The DNA damage response is a complex process that involves a series of checkpoints that are activated when the body experiences damage to its DNA. These checkpoints are critical for ensuring that the body repairs the damage and prevents the damage from being passed on to future generations. When a checkpoint is activated, it causes a build-up of stress and damage to the DNA, which is then repaired.

USP53 is a key regulator of the DNA damage response. It is a protein that is composed of 53 amino acids and has a calculated molecular weight of 64 kDa. It is expressed in various tissues throughout the body, including the brain, heart, and liver. USP53 is involved in the regulation of DNA replication, transcription, and repair.

One of the key functions of USP53 is its role in the regulation of DNA replication. During DNA replication, USP53 helps ensure that the replicated DNA is accurate and free from errors. It does this by monitoring the double helix and making sure that the base pairs are copied correctly. If there are any errors, USP53 will prevent the replication of the DNA and ensure that the error is corrected.

Another function of USP53 is its role in the regulation of transcription. During transcription, USP53 helps ensure that the information in the DNA is properly translated into proteins. It does this by monitoring the RNA molecule and making sure that the information in the DNA is correctly translated into the RNA molecule. If there are any errors, USP53 will prevent the transcription of the DNA and ensure that the error is corrected.

In addition to its role in DNA replication and transcription, USP53 is also involved in the regulation of DNA repair. When the body experiences damage to its DNA, USP53 helps ensure that the body repairs the damage and prevents the damage from being passed on to future generations. It does this by monitoring the DNA and making sure that the repair process is properly initiated.

Overall, USP53 is a critical protein that plays a key role in the regulation of the DNA damage response. Its functions as a regulator of DNA replication, transcription, and repair make it an attractive target for drug development. As research continues to advance, it is likely that new treatments for a variety of diseases will be developed that target USP53.

Protein Name: Ubiquitin Specific Peptidase 53

Functions: Tight junction-associated protein that is involved in the survival of auditory hair cells and hearing. Maybe by modulating the barrier properties and mechanical stability of tight junctions. Has no peptidase activity (PubMed:14715245)

The "USP53 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP53 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase | VAMP1 | VAMP2 | VAMP3 | VAMP4 | VAMP5 | VAMP7 | VAMP8 | VANGL1 | VANGL2 | VAPA | VAPB | VARS1 | VARS2 | Vascular endothelial growth factor receptor (VEGFR) | Vascular endothelial growth factors (VEGF) | VASH1 | VASH1-AS1 | VASH2 | VASN | Vasoactive intestinal polypeptide receptor (VIP-R) | Vasohibin | Vasopressin Receptor | Vasopressin V1 Receptor | VASP | VAT1 | VAT1L | VAV1 | VAV2 | VAV3 | VAV3-AS1 | VAX1 | VAX2 | VBP1 | VCAM1 | VCAN | VCL | VCP | VCPIP1 | VCPKMT | VCX | VCX2 | VCX3A | VCX3B | VCY | VCY1B | VDAC1 | VDAC1P2 | VDAC1P9 | VDAC2 | VDAC2P5 | VDAC3 | VDR | VEGFA | VEGFB | VEGFC | VEGFD | VENTX | VENTXP1 | VENTXP7 | VEPH1 | VEZF1 | VEZT | VGF | VGLL1 | VGLL2